CEO Àλ縻
 
 
 
 
 
HOME >°í°´Áö¿ø > °øÁö»çÇ×
   
  no
  °øÁö»çÇ×
  ´Ù¿î·Îµå
  ÀÚÀ¯°Ô½ÃÆÇ
  no
 
   
 
 
     
 
À̸§ °ü¸®ÀÚ
³¯Â¥ 2022³â 12¿ù 26ÀÏ 14½Ã 44ºÐ 57ÃÊ
Á¦¸ñ [Ç¥ÁØÄÚµå]Ç÷¾×Á¡µµ°Ë»ç(Scanning Capillary Method)[
[Ç¥ÁØÄÚµå]Ç÷¾×Á¡µµ°Ë»ç(Scanning Capillary Method)[WB(EDTA)] Ç¥ÁØÄÚµå Ãß°¡
1. Ç¥Áذ˻çÄڵ带 ´ÙÀ½°ú °°ÀÌ Ãß°¡ÇÏ¿´½À´Ï´Ù.
2. Àû¿ëÀϽà : 2022.12.26 Áï½ÃÀû¿ë

BZD400100XXX200 00 Ç÷¾×Á¡µµ°Ë»ç(Scanning Capillary Method)[WB(EDTA)] D400100
BZD400100XXX200 01 Ç÷¾×Á¡µµ°Ë»ç(À̿ϱâ)[WB(EDTA)]
BZD400100XXX200 02 Ç÷¾×Á¡µµ°Ë»ç(¼öÃà±â)[WB(EDTA)]
BZD400100XXX200 03 Ç÷¾×Á¡µµ°Ë»ç(Àü´Ü·ü:1000/s)[WB(EDTA)]
BZD400100XXX200 04 Ç÷¾×Á¡µµ°Ë»ç(Àü´Ü·ü:150/s)[WB(EDTA)]
BZD400100XXX200 05 Ç÷¾×Á¡µµ°Ë»ç(Àü´Ü·ü:100/s)[WB(EDTA)]
BZD400100XXX200 06 Ç÷¾×Á¡µµ°Ë»ç(Àü´Ü·ü:50/s)[WB(EDTA)]
BZD400100XXX200 07 Ç÷¾×Á¡µµ°Ë»ç(Àü´Ü·ü:10/s)[WB(EDTA)]
BZD400100XXX200 08 Ç÷¾×Á¡µµ°Ë»ç(Àü´Ü·ü:5/s)[WB(EDTA)]
BZEOF3014XXX995 00 Ç÷¾× Áß±Ý¼Ó 4Á¾ ¥± (Al, Pb, Hg, Cd)[S+WB(E)]
BZEOF3014XXX995 01 Ç÷¾× Áß±Ý¼Ó 4Á¾ ¥± (Al (¾Ë·ç¹Ì´½))[S+WB(E)]
BZEOF3014XXX995 02 Ç÷¾× Áß±Ý¼Ó 4Á¾ ¥± (Pb (³³))[S+WB(E)]
BZEOF3014XXX995 03 Ç÷¾× Áß±Ý¼Ó 4Á¾ ¥± (Hg (¼öÀº))[S+WB(E)]
BZEOF3014XXX995 04 Ç÷¾× Áß±Ý¼Ó 4Á¾ ¥± (Cd (Ä«µå¹Å))[S+WB(E)]
 
  Total 377 Articles ( 8 / 38 )
¹øÈ£ Á¦¸ñ À̸§ ³¯Â¥ #
307  [Ç¥ÁØÄÚµå]Pepsinogen I/II Set[Serum] Ç¥ÁØÄÚµå Ãß°¡ °ü¸®ÀÚ23/03/010
306  [Ç¥ÁØÄÚµå]À§ °Ç°­ ¹ÙÀÌ¿À¸¶Ä¿ ÆÐ³Î°Ë»ç[WB(EDTA)] °ü¸®ÀÚ23/01/200
305  [Ç¥ÁØÄÚµå]Ç÷û °£¼¶À¯È­ °Ë»ç(ELF)[Serum] Ç¥ÁØÄÚµå Ãß°¡ °ü¸®ÀÚ23/01/160
304  [Ç¥ÁØÄÚµå]ROMA[Serum] Ç¥ÁØÄÚµå Ãß°¡ °ü¸®ÀÚ23/01/100
303  [Ç¥ÁØÄÚµå]Áúº´À§Çèµµ À¯ÀüÀÚ°Ë»ç 5Á¾[WB(EDTA)] Ç¥ÁØÄÚµå Ãß°¡ °ü¸®ÀÚ23/01/060
302  [Ç¥ÁØÄÚµå]Specific IgE F17 (Hazelnut)[Serum] °ü¸®ÀÚ23/01/050
301  [Ç¥ÁØÄÚµå]Ç÷¾×Á¡µµ°Ë»ç(Scanning Capillary Method)[ °ü¸®ÀÚ22/12/260
300  [Ç¥ÁØÄÚµå]25-OH Vitamin D, Total (RIA)[Serum °ü¸®ÀÚ22/12/210
299  [Ç¥ÁØÄÚµå]Influenza A&B PCR[Throat Swab] Ç¥ÁØÄÚ °ü¸®ÀÚ22/12/130
298  [Ç¥ÁØÄÚµå]HPV Screening PCR(D)[ȯºÎ swab] Ç¥ÁØÄÚµå °ü¸®ÀÚ22/12/020
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [Next 10°³]